SCHEMBL13895136

SCHEMBL13895136

Oc1ccc(CCNc2cc(-c3cc4ccccc4s3)nc(O)n2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR Q13258 5/20 0.61
APP P05067 1/20 0.49
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CNR2 P34972 1/20 0.43
PIK3CD O00329 1/20 0.43
PIK3R1 P27986 1/20 0.43
ILK Q13418 1/20 0.41
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TNIK Q9UKE5 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9912187 0.77 ALDH1A1 (0.44) PTGDRALDH1A1SMN1; SMN2ILKNPC1
SCHEMBL4501379 0.76 PTGDR (1.00) PTGDRCNR2
SCHEMBL13894988 0.74 CNR2 (0.44) PTGDRALDH1A1SMN1; SMN2CNR2ILK
SCHEMBL9912188 0.74 PTGDR (0.64) PTGDRALDH1A1SMN1; SMN2ILKNPC1
SCHEMBL9912208 0.73 PTGDR (0.57) PTGDRALDH1A1SMN1; SMN2MAPTADORA2A
SCHEMBL13894999 0.71 ALDH1A1 (0.47) PTGDRALDH1A1SMN1; SMN2
SCHEMBL13895143 0.71 ALDH1A1 (0.55) PTGDRALDH1A1SMN1; SMN2RAB9ACYP1A2
SCHEMBL9912204 0.70 PTGDR (0.56) PTGDRALDH1A1SMN1; SMN2
SCHEMBL9912189 0.70 BCHE (0.47) PTGDRALDH1A1SMN1; SMN2
SCHEMBL13895056 0.70 ALDH1A1 (0.44) PTGDRALDH1A1SMN1; SMN2LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517889-B2 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists AVENTIS PHARMACEUTICALS, INC. (US) 2009-04-14 US disclosed